G. Dresemann
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 11
- Glioma Diagnosis and Treatment 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 6
- Multiple Myeloma Research and Treatments 3
- Co-authors
- David A. Reardon (2 shared papers)Merrill J. Egorin (1 shared paper)Roger E. McLendon (1 shared paper)Annick Desjardins (1 shared paper)Kimberly Kicielinski (1 shared paper)John H. Sampson (1 shared paper)James J. Vredenburgh (1 shared paper)Jennifer A. Quinn (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Cancer (1 paper)International Journal of Cancer (1 paper)Neuro-Oncology (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
G. Dresemann
13 papers receiving 603 citations
Peers
Comparison fields: 5 of 51
- Genetics 417
- Cancer Research 157
- Hematology 115
- Neurology 83
- Oncology 126
Countries citing papers authored by G. Dresemann
This map shows the geographic impact of G. Dresemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Dresemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Dresemann more than expected).
Fields of papers citing papers by G. Dresemann
This network shows the impact of papers produced by G. Dresemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Dresemann. The network helps show where G. Dresemann may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Dresemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 243 | |
| 2 | 2005 | 132 | |
| 3 | 2009 | 100 | |
| 4 | 2008 | 47 | |
| 5 | 2010 | 41 | |
| 6 | 2010 | 28 | |
| 7 | 2004 | 11 | |
| 8 | 2009 | 4 | |
| 9 | 2006 | 4 | |
| 10 | 2008 | 3 | |
| 11 | Imatinib plus hydroxyurea versus hydroxyurea monotherapy in progressive glioblastoma (GBM) - An international open label randomised phase III study (ambrosia-study) | 2007 | 2 |
| 12 | 2005 | 2 | |
| 13 | 2007 | 2 | |
| 14 | 2008 | 0 | |
| 15 | 2008 | 0 |
About G. Dresemann
G. Dresemann is a scholar working on Genetics, Hematology, Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, having authored 15 papers that have together received 619 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (6 papers), Brain Metastases and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Genetics (417 citations), Cancer Research (157 citations), Hematology (115 citations), Neurology (83 citations) and Oncology (126 citations). G. Dresemann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include David A. Reardon, Merrill J. Egorin, Roger E. McLendon, Annick Desjardins, Kimberly Kicielinski, John H. Sampson, James J. Vredenburgh, Jennifer A. Quinn, James E. Herndon and Sith Sathornsumetee. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, International Journal of Cancer, Neuro-Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.